Thus, it is intuitive that genetic (mutations in the gene encoding a specific PP2A subunits) or functional (e.g. PP2AcY307 phosphorylation, SET overexpression) inactivation of PP2A may represent a step required for cancer development and/or progression. The gene discussed is SET; the disease is cancer.